What 99.8% Purity Actually Means
When a peptide tests at 99.8% purity, that number comes from a specific analytical measurement: High-Performance Liquid Chromatography, or HPLC. It’s not a marketing estimate or a rounded figure. It’s the output of a laboratory instrument that separates and quantifies every molecular component in a sample.
Understanding what that number means — and what it doesn’t — matters for any researcher evaluating peptide quality.
How HPLC Measures Purity
HPLC is the gold standard for peptide purity assessment. The technique works by dissolving a peptide sample in solvent and pushing it through a column packed with specialized material — typically a C18 reversed-phase column. Different molecules interact with the column material differently, causing them to elute (emerge) at different times. A UV detector measures what comes through, producing a chromatogram — a graph of peaks where each peak represents a different molecular species.
The target peptide appears as the dominant peak. Purity is calculated by comparing the area of that peak to the total area of all detected peaks. A result of 99.8% means that 99.8% of all UV-absorbing material in the sample is the target compound. The remaining 0.2% consists of minor impurities.
What’s in the Other 0.2%?
In peptide synthesis, trace impurities are expected and well-understood. That 0.2% typically consists of:
- Truncated sequences — shorter peptide fragments where the synthesis terminated one or two amino acids early
- Deletion sequences — variants where a single amino acid was skipped during solid-phase synthesis
- Counter-ion salts — residual trifluoroacetic acid (TFA) or acetate salts from purification
- Oxidation products — minor modifications from air exposure during handling
None of these are toxic contaminants. They’re predictable byproducts of peptide manufacturing. But the lower that percentage, the cleaner the research compound — and 99.8% represents the upper boundary of what solid-phase synthesis reliably delivers for a 15-amino-acid sequence.
Putting Purity Numbers in Context
Most research-grade peptides on the market fall between 95-98% purity. Anything above 98% is considered high purity. Above 99% is premium. For context, a 2019 analysis in Analytical and Bioanalytical Chemistry found purity ranging from under 50% to over 99% across multiple suppliers for supposedly identical products — meaning the number on the label doesn’t always match what’s in the vial.
Why Third-Party Testing Matters
The purity number is only as trustworthy as the lab that produced it. This is where the distinction between in-house and independent testing becomes critical.
A supplier testing their own product faces an inherent conflict of interest — the same organization selling the compound is certifying its quality. That doesn’t mean in-house results are always wrong, but it removes the independence that makes analytical data trustworthy.
Independent third-party labs — such as Janoshik Analytical (Czech Republic), MZ Biolabs, or university analytical cores — have no financial relationship with any vendor. Their sole business is producing accurate analytical data. When evaluating a supplier’s purity claims, the most reliable evidence comes from labs where the results can be independently verified through the lab’s own portal, not just downloaded as a PDF from the vendor’s website.
Reading a Certificate of Analysis
A thorough COA for a research peptide should include four key components:
1. Identity Confirmation (Mass Spectrometry)
Before assessing purity, you need to confirm the molecule is correct. Mass spectrometry measures molecular weight and compares it to the known theoretical mass. For BPC-157, the expected molecular weight is approximately 1419.53 Da. If the MS result doesn’t match within acceptable tolerance, the compound isn’t what it claims to be — regardless of what the HPLC says about purity.
2. Purity Assessment (HPLC)
This is the headline number — the percentage of target peptide relative to total detected material. For research applications, 98% or higher is the standard. The COA should include the actual chromatogram, not just a summary number. A single dominant peak with minimal noise indicates high-quality synthesis and purification.
3. Endotoxin Testing
Endotoxins are lipopolysaccharide fragments from bacterial cell walls that trigger immune responses in biological systems, potentially compromising experimental results. Testing via the Limulus Amebocyte Lysate (LAL) assay should show levels below acceptable thresholds, usually reported in Endotoxin Units per milligram (EU/mg). High-quality research compounds typically test below 1.0 EU/mg.
4. Sterility Testing
For lyophilized peptides, sterility testing confirms the absence of viable microbial contamination — critical for researchers working with cell cultures or in vitro systems where contamination would invalidate results.
Red Flags in Purity Claims
When evaluating any supplier’s purity documentation:
- No chromatogram: A purity percentage without the actual HPLC graph is an unsupported claim. The chromatogram is the evidence.
- No lab identification: “Tested by our laboratory” without naming the lab or providing verification is meaningless.
- Generic COAs: The same COA used across multiple batches suggests the supplier tested once and applied the result to everything afterward.
- Suspiciously uniform numbers: If every product from a supplier tests at exactly 99.0%, that’s statistically improbable — real analytical data shows natural variation between batches.
- No mass spectrometry: HPLC alone tells you purity but not identity. Without MS confirmation, a 99% pure sample could theoretically be 99% pure of the wrong compound.
The Bottom Line
A purity number is a starting point, not a conclusion. The value of 99.8% — or any purity claim — depends entirely on who measured it, how they measured it, and whether you can verify it. The analytical methodology is well-established. The question is whether the documentation you’re reviewing meets the standard that methodology demands.